News analysis about Paratek Pharmaceuticals (NASDAQ:TSPT) has gained fairly positive quite recently, Accern reports. The analysis company rates the trend of media analysis by studying larger than 20 Million SEC financial documents and social media sites sources in real time. Accern grades analysis of public companies ranging from negative 1 to +1, with ranks nearest to 1 is considered more positive. Paratek Pharmaceuticals received a media impact rank of 0.16 on Accern’s range. Accern also gave press articles concerning the stock a media impact point of 45.2582545898962 out of 100, indicating that most recent media headlines is fairly unlikely to affect on the firms share value next several days.